Invention Application
US20170002094A1 PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA
审中-公开
PLASMA KALLIKREIN结合蛋白及其在治疗放疗中的应用
- Patent Title: PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA
- Patent Title (中): PLASMA KALLIKREIN结合蛋白及其在治疗放疗中的应用
-
Application No.: US15113297Application Date: 2015-01-21
-
Publication No.: US20170002094A1Publication Date: 2017-01-05
- Inventor: Daniel J. Sexton , Burt Adelman , Yung Chyung , Christopher TenHoor , Jon A. Kenniston , Ryan Faucette , Rayan larrobino , Joe Biedenkapp
- Applicant: DYAX CORP.
- Applicant Address: US MA Burlington
- Assignee: Dyax Corp.
- Current Assignee: Dyax Corp.
- Current Assignee Address: US MA Burlington
- International Application: PCT/US15/12212 WO 20150121
- Main IPC: C07K16/40
- IPC: C07K16/40
Abstract:
Provided herein are plasma kallikrein binding proteins such as antibodies binding to active plasma kallikrein and methods of using such proteins in treating hereditary angioedema.
Public/Granted literature
- US11084884B2 Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema Public/Granted day:2021-08-10
Information query
